A detailed history of Snowden Capital Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 39,285 shares of AMGN stock, worth $12.4 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
39,285
Previous 16,921 132.17%
Holding current value
$12.4 Million
Previous $4.81 Million 155.18%
% of portfolio
0.37%
Previous 0.15%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $5.88 Million - $7.14 Million
22,364 Added 132.17%
39,285 $12.3 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $1.64 Million - $1.98 Million
6,114 Added 56.57%
16,921 $4.81 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $90,773 - $102,403
355 Added 3.4%
10,807 $3.11 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $460,476 - $571,694
-2,106 Reduced 16.77%
10,452 $2.81 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $560,744 - $663,069
2,617 Added 26.33%
12,558 $2.79 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $708,754 - $863,852
3,139 Added 46.15%
9,941 $2.4 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $125,737 - $159,764
-549 Reduced 7.47%
6,802 $1.79 Million
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $44,892 - $50,630
200 Added 2.8%
7,351 $1.66 Million
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $158,728 - $176,637
688 Added 10.65%
7,151 $1.74 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $806,913 - $892,657
3,680 Added 132.23%
6,463 $1.56 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $553,483 - $633,410
2,783 New
2,783 $626,000
Q3 2021

Feb 05, 2024

SELL
$212.27 - $248.7 $1.23 Million - $1.44 Million
-5,788 Reduced 55.38%
4,664 $992 Million
Q2 2021

Jan 08, 2024

SELL
$233.58 - $259.14 $350,603 - $388,969
-1,501 Reduced 25.3%
4,431 $1.08 Billion
Q1 2021

Jan 08, 2024

BUY
$221.91 - $258.6 $201,494 - $234,808
908 Added 18.07%
5,932 $1.48 Billion
Q4 2020

Jan 08, 2024

BUY
$216.38 - $257.67 $480,363 - $572,027
2,220 Added 79.17%
5,024 $1.16 Billion
Q3 2020

Jan 08, 2024

BUY
$234.65 - $260.95 $8,916 - $9,916
38 Added 1.37%
2,804 $713 Million
Q2 2020

Jan 08, 2024

SELL
$197.81 - $242.74 $119,279 - $146,372
-603 Reduced 17.9%
2,766 $652 Million
Q1 2020

Jan 08, 2024

SELL
$182.24 - $241.7 $6,196 - $8,217
-34 Reduced 1.0%
3,369 $683 Million
Q4 2019

Jan 30, 2024

BUY
$189.21 - $243.2 $23,840 - $30,643
126 Added 3.84%
3,403 $820 Million
Q4 2019

Jan 08, 2024

BUY
$189.21 - $243.2 $23,840 - $30,643
126 Added 3.84%
3,403 $820 Million
Q3 2019

Jan 30, 2024

SELL
$174.11 - $208.62 $92,452 - $110,777
-531 Reduced 13.94%
3,277 $634 Million
Q3 2019

Jan 08, 2024

SELL
$174.11 - $208.62 $3.18 Million - $3.81 Million
-18,240 Reduced 84.77%
3,277 $634 Million
Q2 2019

Jan 30, 2024

SELL
$166.7 - $195.41 $1.11 Million - $1.3 Million
-6,644 Reduced 63.57%
3,808 $702 Million
Q2 2019

Jan 08, 2024

BUY
$166.7 - $195.41 $2.93 Million - $3.43 Million
17,558 Added 443.5%
21,517 $706 Million
Q1 2019

Jan 08, 2024

SELL
$180.87 - $203.88 $5,245 - $5,912
-29 Reduced 0.73%
3,959 $752 Million
Q4 2018

Jan 08, 2024

SELL
$178.4 - $208.25 $201,413 - $235,114
-1,129 Reduced 22.06%
3,988 $776 Million
Q3 2018

Jan 08, 2024

BUY
$185.29 - $208.89 $136,929 - $154,369
739 Added 16.88%
5,117 $1.06 Billion
Q2 2018

Jan 08, 2024

SELL
$166.05 - $186.51 $25,903 - $29,095
-156 Reduced 3.44%
4,378 $808 Million
Q1 2018

Jan 08, 2024

SELL
$169.43 - $198.0 $1.06 Million - $1.23 Million
-6,233 Reduced 57.89%
4,534 $773 Million
Q4 2017

Jan 08, 2024

BUY
$168.79 - $188.59 $250,821 - $280,244
1,486 Added 16.01%
10,767 $1.87 Billion
Q3 2017

Jan 08, 2024

BUY
$167.29 - $191.0 $160,096 - $182,787
957 Added 11.5%
9,281 $1.73 Billion
Q2 2017

Jan 08, 2024

BUY
N/A
985 Added 13.42%
8,324 $1.43 Billion
Q1 2017

Jan 08, 2024

BUY
N/A
750 Added 11.38%
7,339 $1.2 Billion
Q4 2016

Jan 08, 2024

SELL
N/A
-3,863
6,589 $963 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.